General Publications

Rethinking clinical strategy for treating dry eye disease

Realizing Cyclosporin’s Untapped Potential

“Smaller drops, bigger impact”

Christian Roesky discusses the underserved condition of dry eye disease

Ocular surface disease (OSD) is extremely common – and though it is not always the primary complaint, it isimplicated in many cases that present to ophthalmic practices.

Clinical and laboratory studies performed over the past few decades have discovered that dry eye is a chronic inflammatory disease that can be initiated by numerous extrinsic or intrinsic factors [...]

Traditional aqueous vehicles for topical ophthalmic medications suffer from a number of limitations.

Novaliq GmbH, based in Heidelberg, Germany, is a drug delivery company that is developing a superior generation of ocular formulations.

One of the biggest challenges currently facing the pharmaceutical industry is the development of more efficient drug delivery systems.

The global market for ophthalmic drugs is expected to hit $30.5bn by 2020, fueled in part by the rise in age-relate eye conditions like glaucoma, dry eye and macular degeneration.